Search results
Treatment of the Diabetic Heart Failure Patient
Author(s):
Mikhail Kosiborod
,
Mark Petrie
Added:
3 years ago
Video Series
Author(s):
Anjali Agarwalla
,
Jadry Gruen
,
Carli Peters
,
et al
Added:
2 years ago
Author(s):
Chris Wai Hang Lo
,
Yue Fei
,
Bernard Man Yung Cheung
Added:
3 years ago
Author(s):
Thomas A Zelniker
,
Eugene Braunwald
Added:
3 years ago
With progressive ageing and the growing incidence of obesity in the population, the prevalence of type 2 diabetes (T2D) has been rising rapidly and has become a major cause of death and disability worldwide.1 It is well established that atherosclerotic cardiovascular disease (ASCVD) and renal failure are responsible for a large majority of deaths in patients with T2D.2-4 Over the past decade, the…
View more
Author(s):
Muhammad Shahzeb Khan
,
Javed Butler
Added:
4 years ago
In 2008, the European Medicines Agency and US Food and Drug Administration (FDA) issued industry guidance stating that all future novel glucose-lowering agent trials must undergo routine cardiovascular risk evaluation either before approval or as a post-marketing commitment.1 This mandated that all cardiovascular endpoint committees prospectively adjudicate all major adverse cardiovascular events…
View more
Author(s):
Giuseppe Rosano
,
Cristiana Vitale
,
Petar M Seferovic
Added:
3 years ago
Diabetes mellitus is highly prevalent amongst patients with heart failure, especially those with heart failure and preserved ejection fraction (HFpEF), and patients with the two conditions have a higher risk of mortality compared with patients without diabetes or heart failure.1–3 Diabetic patients have an increased risk of developing heart failure because of the abnormal cardiac handling of…
View more
Author(s):
Aliza Hussain
,
Arunima Misra
,
Biykem Bozkurt
Added:
2 years ago
De Novo HF Versus ADCHF
Author(s):
Wilson Matthew Raffaello
,
Joshua Henrina
,
Ian Huang
,
et al
Added:
3 years ago
Article
Author(s):
Gabriele Fragasso
Added:
3 years ago
The development of heart failure is rarely dependent on primary alterations of cardiac metabolism. The majority of heart failure cases result from diseases of the cardiac muscle, most frequently ischaemic heart disease. However, whatever the cause of heart failure, the net result will be depletion of myocardial adenosine triphosphate (ATP), phosphocreatine and creatine kinase levels with…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article